Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Maximum tubular reabsorption capacity for glucose and renal hemodynamcis during rapid hypertonic glucose infusion in normal and diabetic subjects.

× No keyword cloud information.

52 in total

Review 1. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Authors: Ele Ferrannini; Anna Solini
Journal: Nat Rev Endocrinol Date: 2012-02-07 Impact factor: 43.330

2. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: normalization by insulin-treatment.

Authors: C E Mogensen; M J Andersen
Journal: Diabetologia Date: 1975-06 Impact factor: 10.122

Review 3. Renal glucose transporters: novel targets for hyperglycemia management.

Authors: Amanda Mather; Carol Pollock
Journal: Nat Rev Nephrol Date: 2010-03-30 Impact factor: 28.314

Review 4. Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin.

Authors: Takeshi Kadokura; Wenhui Zhang; Walter Krauwinkel; Stefanie Leeflang; James Keirns; Yuta Taniuchi; Ikumi Nakajo; Ronald Smulders
Journal: Clin Pharmacokinet Date: 2014-11 Impact factor: 6.447

Review 5. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.

Authors: Volker Vallon; Scott C Thomson
Journal: Diabetologia Date: 2016-11-22 Impact factor: 10.122

6. Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview.

Authors: Juan F Mosley; Lillian Smith; Emily Everton; Chris Fellner
Journal: P T Date: 2015-07

7. Effects of glucose on bicarbonate reabsorption in the dog kidney.

Authors: W N Suki; C S Herbert; B J Stinebaugh; M Martinez-Maldonado; G Eknoyan
Journal: J Clin Invest Date: 1974-07 Impact factor: 14.808

Review 8. Emerging treatments for post-transplantation diabetes mellitus.

Authors: Trond Jenssen; Anders Hartmann
Journal: Nat Rev Nephrol Date: 2015-04-28 Impact factor: 28.314

Review 9. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors: Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal: Nat Rev Nephrol Date: 2016-12-12 Impact factor: 28.314

10. [Studies on the pharmacokinetics of carbohydrates as a basis for their use in parenteral feeding].

Authors: F Matzkies
Journal: Z Ernahrungswiss Date: 1975-09